In today’s recent session, 0.88 million shares of the Guardant Health Inc (NASDAQ:GH) have been traded, and its beta is 0.96. Most recently the company’s share price was $17.04, and it changed around $0.97 or 6.04% from the last close, which brings the market valuation of the company to $2.07B. GH at last check was trading at a discount to its 52-week high of $41.06, offering almost -140.96% off that amount. The share price’s 52-week low was $15.81, which indicates that the recent value has risen by an impressive 7.22% since then. We note from Guardant Health Inc’s average daily trading volume that its 3-month average coming to 2.00 million.
Guardant Health Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.43. If we narrow it down even further, the data shows that 0 out of 4 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 0 recommended GH as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight.
Guardant Health Inc (NASDAQ:GH) trade information
Instantly GH has been showing a green trend so far today with a performance of 6.04% on intraday trading today. The performance over the last five days has remained in the red territory. The company’s shares are currently down -37.00% year-to-date, but still down -0.11% over the last five days. On the other hand, Guardant Health Inc (NASDAQ:GH) is -2.95% down in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $75.67, which translates to bulls needing to increase their stock price by 77.48% from its current value. Analyst projections state that GH is forecast to be at a low of $40 and a high of $125.
Guardant Health Inc (GH) estimates and forecasts
Guardant Health Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -34.43 percent over the past six months and at a 37.62% annual growth rate that is well above the industry average of 13.30%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -8.88%. Guardant Health Inc earnings are expected to increase by 23.51% in 2024, but the outlook is positive 27.80% per year for the next five years.
